Image-Guided Radiation Therapy Market Report 2026

The image-guided radiation therapy market size has grown steadily in recent years. It will grow from $1.99 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to rising global cancer incidence, advancements in imaging technologies for oncology, increasing adoption of linac-based radiotherapy systems, improved clinical outcomes with image guidance, expansion of radiotherapy infrastructure in developed regions.

The image-guided radiation therapy market size is expected to see steady growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to integration of AI in treatment planning and imaging, growing demand for non-invasive cancer treatments, rising investments in advanced radiotherapy centers, increasing adoption of proton and particle therapy, expanding access to cancer care in emerging markets. Major trends in the forecast period include increasing adoption of precision radiation delivery, growing integration of real-time imaging in radiotherapy, rising demand for personalized cancer treatment planning, expansion of stereotactic and proton-based therapies, increasing focus on reducing radiation-induced toxicity.

The rising incidence of cancer is expected to drive growth in the image-guided radiation therapy (IGRT) market in the coming years. Cancer, characterized by the uncontrolled proliferation and spread of abnormal cells, often requires precise treatment to maximize effectiveness while minimizing harm to healthy tissue. IGRT provides targeted radiation to cancer cells, reducing side effects and improving treatment outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based organization, reported that over 3 million people in the UK were living with cancer in 2024, with projections reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Thus, the increasing cancer prevalence is driving demand for IGRT.

Key companies in the IGRT market are advancing technology to improve treatment precision and adaptability. For instance, Accuray Incorporated, a US-based manufacturer of radiation therapy systems, partnered with Limbus AI, a Canada-based artificial intelligence company, to launch the Cenos platform for its Radixact System in October 2023. Cenos enables online adaptive radiotherapy, allowing healthcare professionals to adjust a treatment plan in real time during a patient’s session. It supports a wide range of cancers - including breast, prostate, lung, and head and neck cancers - as well as complex treatments like total marrow irradiation. The platform features a high-speed multileaf collimator, a fully integrated system, and the Tomo C platform, providing compromise-free treatment while allowing real-time plan modifications between sessions.

In October 2023, Elekta AB, a Sweden-based provider of precision radiotherapy and brachytherapy systems, acquired the Xoft business from iCAD Inc. for approximately $5.5 million. This acquisition expands Elekta’s technological capabilities by integrating Xoft’s low-energy X-ray electronic brachytherapy (eBx) system into its portfolio, offering minimally shielded and intraoperative treatment options. Xoft, a US-based company, specializes in the Axxent eBx System, which delivers localized radiation via a miniaturized X-ray source for multiple cancer indications, including breast, skin, gynecological, and brain cancers.

Major companies operating in the image-guided radiation therapy market are Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Varian Medical Systems Inc., Elekta AB, Canon Medical Systems R&D (Dalian) Co. Ltd., Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Standard Imaging Inc., CIVCO Radiotherapy Inc., RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation, RefleXion Medical Inc.

North America was the largest region in the image-guided radiation therapy market in 2025. The regions covered in the image-guided radiation therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the image-guided radiation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the image-guided radiation therapy market by increasing costs of imported linear accelerators, imaging components, detectors, and precision electronics. These impacts are most pronounced in emerging markets and regions dependent on advanced medical device imports, such as Asia-Pacific and parts of Latin America. However, tariffs are also encouraging domestic manufacturing, technology localization, and strategic partnerships, which may strengthen long-term supply resilience and regional adoption of IGRT systems.

The image-guided radiation therapy market research report is one of a series of new reports that provides image-guided radiation therapy market statistics, including image-guided radiation therapy industry global market size, regional shares, competitors with a image-guided radiation therapy market share, detailed image-guided radiation therapy market segments, market trends and opportunities, and any further data you may need to thrive in the image-guided radiation therapy industry. This image-guided radiation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Image-guided radiation therapy (IGRT) is a medical technique in radiation oncology that delivers precise and targeted radiation to cancerous tumors. It is designed to minimize treatment toxicity while allowing the safe administration of accurate radiation doses for patients with cancer.

The primary product types in IGRT include 4D gating and 4D RT, linear accelerators (linacs), PET- and MRI-guided radiation therapy, portal imaging, and CT scanning. 4D gating and 4D RT involve monitoring and synchronizing a patient’s respiratory or cardiac motion with radiation delivery or imaging to ensure accurate targeting. Key procedures include intensity-modulated radiation therapy (IMRT), 3D conformal radiation therapy, stereotactic therapy, proton beam therapy, and particle therapy. These procedures are applied across various cancers, including lung, prostate, head and neck, gynecological, and gastrointestinal cancers, with end-users including hospitals and independent radiotherapy centers.

The image-guided radiation therapy market includes revenues earned by entities by providing treatment using various imaging technological services such as positron emission tomography, 2D radiotherapy technology, and 3D radiotherapy technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The image-guided radiation therapy market consists of sales of cone-beam imaging systems, immobilization devices, ultrasound imaging, adaptive radiation therapy systems, and cameras. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.